|
G |
BCL2 |
BCL2 apoptosis regulator |
decreases expression |
EXP |
gardenin B results in decreased expression of BCL2 protein |
CTD |
PMID:27423764 |
|
NCBI chr18:63,123,346...63,320,090
Ensembl chr18:63,123,346...63,320,128
|
|
G |
CASP2 |
caspase 2 |
multiple interactions |
EXP |
gardenin B results in increased cleavage of and results in increased activity of CASP2 protein |
CTD |
PMID:27423764 |
|
NCBI chr 7:143,288,351...143,307,696
Ensembl chr 7:143,288,215...143,307,696
|
|
G |
CASP3 |
caspase 3 |
multiple interactions |
EXP |
gardenin B results in increased cleavage of and results in increased activity of CASP3 protein |
CTD |
PMID:27423764 |
|
NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062
|
|
G |
CASP8 |
caspase 8 |
multiple interactions |
EXP |
gardenin B results in increased cleavage of and results in increased activity of CASP8 protein |
CTD |
PMID:27423764 |
|
NCBI chr 2:201,233,463...201,287,711
Ensembl chr 2:201,233,443...201,361,836
|
|
G |
CASP9 |
caspase 9 |
multiple interactions |
EXP |
gardenin B results in increased cleavage of and results in increased activity of CASP9 protein |
CTD |
PMID:27423764 |
|
NCBI chr 1:15,491,401...15,524,912
Ensembl chr 1:15,490,832...15,526,534
|
|
G |
PARP1 |
poly(ADP-ribose) polymerase 1 |
increases cleavage |
EXP |
gardenin B results in increased cleavage of PARP1 protein |
CTD |
PMID:27423764 |
|
NCBI chr 1:226,360,691...226,408,093
Ensembl chr 1:226,360,210...226,408,154
|
|
|
G |
ABCB1 |
ATP binding cassette subfamily B member 1 |
decreases activity multiple interactions |
EXP |
sinensetin analog results in decreased activity of ABCB1 protein; sinensetin results in decreased activity of ABCB1 protein sinensetin analog inhibits the reaction [ABCB1 protein results in increased transport of Digoxin]; sinensetin inhibits the reaction [ABCB1 protein results in increased transport of Digoxin] |
CTD |
PMID:30790579 |
|
NCBI chr 7:87,503,017...87,713,295
Ensembl chr 7:87,503,017...87,713,323
|
|
G |
CYP1A1 |
cytochrome P450 family 1 subfamily A member 1 |
increases metabolic processing |
EXP |
CYP1A1 protein results in increased metabolism of sinensetin |
CTD |
PMID:19666078 |
|
NCBI chr15:74,719,542...74,725,528
Ensembl chr15:74,719,542...74,725,536
|
|
G |
CYP1A2 |
cytochrome P450 family 1 subfamily A member 2 |
increases metabolic processing |
EXP |
CYP1A2 protein results in increased metabolism of sinensetin |
CTD |
PMID:19666078 |
|
NCBI chr15:74,748,845...74,756,607
Ensembl chr15:74,748,845...74,756,607
|
|
G |
CYP1B1 |
cytochrome P450 family 1 subfamily B member 1 |
increases metabolic processing |
EXP |
CYP1B1 protein results in increased metabolism of sinensetin |
CTD |
PMID:19666078 |
|
NCBI chr 2:38,067,509...38,076,151
Ensembl chr 2:38,066,973...38,109,902
|
|
G |
CYP3A4 |
cytochrome P450 family 3 subfamily A member 4 |
multiple interactions increases activity |
EXP |
[[sinensetin analog results in increased activity of CYP3A4 protein] which results in increased metabolism of Midazolam] which results in increased chemical synthesis of 1-hydroxymethylmidazolam; [[sinensetin results in increased activity of CYP3A4 protein] which results in increased metabolism of Midazolam] which results in increased chemical synthesis of 1-hydroxymethylmidazolam; [sinensetin analog results in increased activity of CYP3A4 protein] which results in increased metabolism of Midazolam; [sinensetin results in increased activity of CYP3A4 protein] which results in increased metabolism of Midazolam sinensetin analog results in increased activity of CYP3A4 protein; sinensetin results in increased activity of CYP3A4 protein |
CTD |
PMID:31756459 |
|
NCBI chr 7:99,756,967...99,784,184
Ensembl chr 7:99,756,960...99,784,248
|
|
G |
SLC2A1 |
solute carrier family 2 member 1 |
multiple interactions |
EXP |
sinensetin inhibits the reaction [SLC2A1 protein results in increased uptake of 2-(N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)-2-deoxyglucose] |
CTD |
PMID:36870413 |
|
NCBI chr 1:42,925,353...42,958,868
Ensembl chr 1:42,925,353...42,958,893
|
|
G |
SLCO1B1 |
solute carrier organic anion transporter family member 1B1 |
multiple interactions decreases activity |
EXP |
[sinensetin results in decreased activity of SLCO1B1 protein] which results in decreased uptake of Fluvastatin |
CTD |
PMID:32259555 |
|
NCBI chr12:21,131,194...21,239,796
Ensembl chr12:21,131,194...21,239,796
|
|
G |
SLCO1C1 |
solute carrier organic anion transporter family member 1C1 |
decreases activity multiple interactions |
ISO |
sinensetin results in decreased activity of SLCO1B1 protein [sinensetin results in decreased activity of SLCO1B1 protein] which results in decreased uptake of Bosentan |
CTD |
PMID:32259555 |
|
NCBI chr12:20,695,332...20,753,386
Ensembl chr12:20,695,332...20,753,386
|
|
|
G |
ABCB1 |
ATP binding cassette subfamily B member 1 |
decreases activity increases activity decreases expression multiple interactions |
EXP |
tangeretin results in decreased activity of ABCB1 protein tangeretin results in increased activity of ABCB1 protein tangeretin results in decreased expression of ABCB1 protein tangeretin inhibits the reaction [ABCB1 protein results in decreased uptake of Daunorubicin]; tangeretin inhibits the reaction [ABCB1 protein results in decreased uptake of Rhodamine 123]; tangeretin inhibits the reaction [ABCB1 protein results in increased transport of Digoxin]; tangeretin inhibits the reaction [Elacridar inhibits the reaction [ABCB1 protein results in decreased uptake of Rhodamine 123]]; Verapamil inhibits the reaction [tangeretin results in increased activity of ABCB1 protein] |
CTD |
PMID:30790579 PMID:34217736 |
|
NCBI chr 7:87,503,017...87,713,295
Ensembl chr 7:87,503,017...87,713,323
|
|
G |
CASP3 |
caspase 3 |
multiple interactions |
ISO EXP |
tangeretin inhibits the reaction [Cisplatin results in increased expression of CASP3 protein] AGN 193109 inhibits the reaction [tangeretin results in decreased expression of and results in increased cleavage of CASP3 protein]; tangeretin results in decreased expression of and results in increased cleavage of CASP3 protein |
CTD |
PMID:27616468 PMID:33058988 |
|
NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062
|
|
G |
CASP8 |
caspase 8 |
multiple interactions increases cleavage |
EXP |
AGN 193109 inhibits the reaction [tangeretin results in increased cleavage of CASP8 protein] |
CTD |
PMID:33058988 |
|
NCBI chr 2:201,233,463...201,287,711
Ensembl chr 2:201,233,443...201,361,836
|
|
G |
CASP9 |
caspase 9 |
multiple interactions |
EXP |
AGN 193109 inhibits the reaction [tangeretin results in decreased expression of and results in increased cleavage of CASP9 protein]; tangeretin results in decreased expression of and results in increased cleavage of CASP9 protein |
CTD |
PMID:33058988 |
|
NCBI chr 1:15,491,401...15,524,912
Ensembl chr 1:15,490,832...15,526,534
|
|
G |
CAT |
catalase |
multiple interactions |
ISO |
tangeretin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased activity of CAT protein] |
CTD |
PMID:24995432 |
|
NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060
|
|
G |
CYB5A |
cytochrome b5 type A |
multiple interactions |
ISO |
tangeretin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYB5A protein] |
CTD |
PMID:24995432 |
|
NCBI chr18:74,250,846...74,291,963
Ensembl chr18:74,250,846...74,291,973
|
|
G |
CYBB |
cytochrome b-245 beta chain |
multiple interactions |
ISO |
tangeretin inhibits the reaction [NG-Nitroarginine Methyl Ester results in increased expression of CYBB protein] |
CTD |
PMID:32479886 |
|
NCBI chr X:37,780,059...37,813,461
Ensembl chr X:37,780,018...37,813,461
|
|
G |
CYP1A1 |
cytochrome P450 family 1 subfamily A member 1 |
multiple interactions increases expression increases metabolic processing |
EXP |
tangeretin inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA]; tangeretin inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 protein] tangeretin results in increased expression of CYP1A1 protein CYP1A1 protein results in increased metabolism of tangeretin |
CTD |
PMID:17090139 PMID:29626627 |
|
NCBI chr15:74,719,542...74,725,528
Ensembl chr15:74,719,542...74,725,536
|
|
G |
CYP1A2 |
cytochrome P450 family 1 subfamily A member 2 |
multiple interactions increases metabolic processing |
EXP |
tangeretin inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] CYP1A2 protein results in increased metabolism of tangeretin |
CTD |
PMID:17090139 PMID:29626627 |
|
NCBI chr15:74,748,845...74,756,607
Ensembl chr15:74,748,845...74,756,607
|
|
G |
CYP1B1 |
cytochrome P450 family 1 subfamily B member 1 |
increases expression increases metabolic processing |
EXP |
tangeretin results in increased expression of CYP1B1 protein CYP1B1 protein results in increased metabolism of tangeretin |
CTD |
PMID:29626627 |
|
NCBI chr 2:38,067,509...38,076,151
Ensembl chr 2:38,066,973...38,109,902
|
|
G |
CYP3A4 |
cytochrome P450 family 3 subfamily A member 4 |
increases activity multiple interactions |
EXP |
tangeretin results in increased activity of CYP3A4 protein [[tangeretin results in increased activity of CYP3A4 protein] which results in increased metabolism of Midazolam] which results in increased chemical synthesis of 1-hydroxymethylmidazolam; [tangeretin results in increased activity of CYP3A4 protein] which results in increased metabolism of Midazolam |
CTD |
PMID:31756459 |
|
NCBI chr 7:99,756,967...99,784,184
Ensembl chr 7:99,756,960...99,784,248
|
|
G |
DNMT1 |
DNA methyltransferase 1 |
decreases expression |
ISO |
tangeretin metabolite results in decreased expression of DNMT1 protein; tangeretin results in decreased expression of DNMT1 protein |
CTD |
PMID:37517432 |
|
NCBI chr19:10,133,346...10,194,953
Ensembl chr19:10,133,342...10,231,286
|
|
G |
DNMT3A |
DNA methyltransferase 3 alpha |
decreases expression |
ISO |
tangeretin metabolite results in decreased expression of DNMT3A protein; tangeretin results in decreased expression of DNMT3A protein |
CTD |
PMID:37517432 |
|
NCBI chr 2:25,227,874...25,342,590
Ensembl chr 2:25,227,855...25,342,590
|
|
G |
DNMT3B |
DNA methyltransferase 3 beta |
decreases expression |
ISO |
tangeretin metabolite results in decreased expression of DNMT3B protein; tangeretin results in decreased expression of DNMT3B protein |
CTD |
PMID:37517432 |
|
NCBI chr20:32,762,385...32,809,356
Ensembl chr20:32,762,385...32,809,359
|
|
G |
GSR |
glutathione-disulfide reductase |
multiple interactions |
ISO |
tangeretin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased activity of GSR protein] |
CTD |
PMID:24995432 |
|
NCBI chr 8:30,678,066...30,727,846
Ensembl chr 8:30,678,066...30,727,846
|
|
G |
HDAC1 |
histone deacetylase 1 |
decreases expression |
ISO |
tangeretin metabolite results in decreased expression of HDAC1 protein; tangeretin results in decreased expression of HDAC1 protein |
CTD |
PMID:37517432 |
|
NCBI chr 1:32,292,083...32,333,626
Ensembl chr 1:32,292,083...32,333,635
|
|
G |
HDAC2 |
histone deacetylase 2 |
decreases expression |
ISO |
tangeretin metabolite results in decreased expression of HDAC2 protein; tangeretin results in decreased expression of HDAC2 protein |
CTD |
PMID:37517432 |
|
NCBI chr 6:113,933,028...113,971,148
Ensembl chr 6:113,933,028...114,011,308
|
|
G |
HDAC3 |
histone deacetylase 3 |
decreases expression |
ISO |
tangeretin metabolite results in decreased expression of HDAC3 protein; tangeretin results in decreased expression of HDAC3 protein |
CTD |
PMID:37517432 |
|
NCBI chr 5:141,620,881...141,636,849
Ensembl chr 5:141,620,876...141,636,849
|
|
G |
HDAC4 |
histone deacetylase 4 |
decreases expression |
ISO |
tangeretin metabolite results in decreased expression of HDAC4 protein; tangeretin results in decreased expression of HDAC4 protein |
CTD |
PMID:37517432 |
|
NCBI chr 2:239,048,168...239,401,649
Ensembl chr 2:239,048,168...239,401,654
|
|
G |
HDAC8 |
histone deacetylase 8 |
decreases expression |
ISO |
tangeretin metabolite results in decreased expression of HDAC8 protein; tangeretin results in decreased expression of HDAC8 protein |
CTD |
PMID:37517432 |
|
NCBI chr X:72,329,516...72,572,843
Ensembl chr X:72,329,516...72,573,101
|
|
G |
HMOX1 |
heme oxygenase 1 |
multiple interactions increases expression |
ISO |
tangeretin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of HMOX1 mRNA]; tangeretin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of HMOX1 protein] tangeretin metabolite results in increased expression of HMOX1 mRNA; tangeretin metabolite results in increased expression of HMOX1 protein; tangeretin results in increased expression of HMOX1 mRNA; tangeretin results in increased expression of HMOX1 protein |
CTD |
PMID:24995432 PMID:37517432 |
|
NCBI chr22:35,381,096...35,394,207
Ensembl chr22:35,380,361...35,394,214
|
|
G |
IL10 |
interleukin 10 |
multiple interactions |
ISO |
tangeretin inhibits the reaction [Cisplatin results in decreased expression of IL10 protein] |
CTD |
PMID:27616468 |
|
NCBI chr 1:206,767,602...206,772,494
Ensembl chr 1:206,767,602...206,774,541
|
|
G |
IL1B |
interleukin 1 beta |
multiple interactions |
ISO |
tangeretin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of IL1B protein] |
CTD |
PMID:24995432 |
|
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
|
|
G |
IL6 |
interleukin 6 |
multiple interactions |
ISO |
tangeretin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of IL6 protein] |
CTD |
PMID:24995432 |
|
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
|
|
G |
KEAP1 |
kelch like ECH associated protein 1 |
multiple interactions |
ISO |
tangeretin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of KEAP1 mRNA]; tangeretin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of KEAP1 protein] |
CTD |
PMID:24995432 |
|
NCBI chr19:10,486,125...10,503,356
Ensembl chr19:10,486,125...10,503,558
|
|
G |
NFE2L2 |
NFE2 like bZIP transcription factor 2 |
multiple interactions decreases methylation increases expression |
ISO |
tangeretin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of NFE2L2 mRNA]; tangeretin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of NFE2L2 protein]; tangeretin inhibits the reaction [Cisplatin results in increased expression of NFE2L2 protein] tangeretin metabolite results in decreased methylation of NFE2L2 promoter; tangeretin results in decreased methylation of NFE2L2 promoter tangeretin metabolite results in increased expression of NFE2L2 mRNA; tangeretin metabolite results in increased expression of NFE2L2 protein; tangeretin results in increased expression of NFE2L2 mRNA; tangeretin results in increased expression of NFE2L2 protein |
CTD |
PMID:24995432 PMID:27616468 PMID:37517432 |
|
NCBI chr 2:177,230,303...177,264,727
Ensembl chr 2:177,218,667...177,392,756
|
|
G |
NOS2 |
nitric oxide synthase 2 |
multiple interactions |
ISO |
tangeretin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of NOS2 protein]; tangeretin inhibits the reaction [Cisplatin results in increased expression of NOS2 protein] |
CTD |
PMID:24995432 PMID:27616468 |
|
NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529
|
|
G |
NOS3 |
nitric oxide synthase 3 |
multiple interactions |
ISO |
tangeretin inhibits the reaction [NG-Nitroarginine Methyl Ester results in decreased expression of NOS3 protein] |
CTD |
PMID:32479886 |
|
NCBI chr 7:150,991,017...151,014,588
Ensembl chr 7:150,991,017...151,014,588
|
|
G |
NQO1 |
NAD(P)H quinone dehydrogenase 1 |
multiple interactions increases expression |
ISO |
tangeretin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of NQO1 mRNA]; tangeretin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of NQO1 protein] tangeretin metabolite results in increased expression of NQO1 mRNA; tangeretin metabolite results in increased expression of NQO1 protein; tangeretin results in increased expression of NQO1 mRNA; tangeretin results in increased expression of NQO1 protein |
CTD |
PMID:24995432 PMID:37517432 |
|
NCBI chr16:69,709,401...69,726,560
Ensembl chr16:69,706,996...69,726,668
|
|
G |
PARP1 |
poly(ADP-ribose) polymerase 1 |
multiple interactions |
EXP |
AGN 193109 inhibits the reaction [tangeretin results in decreased expression of and results in increased cleavage of PARP1 protein]; tangeretin results in decreased expression of and results in increased cleavage of PARP1 protein |
CTD |
PMID:33058988 |
|
NCBI chr 1:226,360,691...226,408,093
Ensembl chr 1:226,360,210...226,408,154
|
|
G |
PKM |
pyruvate kinase M1/2 |
increases activity |
EXP |
tangeretin results in increased activity of PKM protein |
CTD |
PMID:25388478 |
|
NCBI chr15:72,199,029...72,231,591
Ensembl chr15:72,199,029...72,231,819
|
|
G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions |
ISO |
tangeretin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of PTGS2 protein] |
CTD |
PMID:24995432 |
|
NCBI chr 1:186,671,791...186,680,423
Ensembl chr 1:186,671,791...186,680,922
|
|
G |
RARB |
retinoic acid receptor beta |
increases expression multiple interactions |
EXP |
tangeretin results in increased expression of RARB mRNA; tangeretin results in increased expression of RARB protein AGN 193109 inhibits the reaction [tangeretin results in increased expression of RARB protein] |
CTD |
PMID:33058988 |
|
NCBI chr 3:24,829,321...25,597,932
Ensembl chr 3:24,687,887...25,597,932
|
|
G |
RELA |
RELA proto-oncogene, NF-kB subunit |
multiple interactions |
ISO |
tangeretin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of RELA mRNA]; tangeretin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of RELA protein]; tangeretin inhibits the reaction [Cisplatin results in increased expression of RELA protein] |
CTD |
PMID:24995432 PMID:27616468 |
|
NCBI chr11:65,653,601...65,663,857
Ensembl chr11:65,653,599...65,663,090
|
|
G |
STAR |
steroidogenic acute regulatory protein |
multiple interactions |
ISO |
tangeretin inhibits the reaction [NG-Nitroarginine Methyl Ester results in decreased expression of STAR protein] |
CTD |
PMID:32479886 |
|
NCBI chr 8:38,142,700...38,150,952
Ensembl chr 8:38,142,700...38,150,992
|
|
G |
TNF |
tumor necrosis factor |
multiple interactions |
ISO |
tangeretin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of TNF mRNA]; tangeretin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of TNF protein]; tangeretin inhibits the reaction [Cisplatin results in increased expression of TNF protein] |
CTD |
PMID:24995432 PMID:27616468 |
|
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
|
|
G |
UGT1A1 |
UDP glucuronosyltransferase family 1 member A1 |
increases expression |
ISO |
tangeretin metabolite results in increased expression of UGT1A1 mRNA; tangeretin metabolite results in increased expression of UGT1A1 protein; tangeretin results in increased expression of UGT1A1 mRNA; tangeretin results in increased expression of UGT1A1 protein |
CTD |
PMID:37517432 |
|
NCBI chr 2:233,760,270...233,773,300
Ensembl chr 2:233,760,270...233,773,300
|
|